ACP-105

Overview

ACP-105 is a novel non-steroidal SARM that, in animal studies, delivered ~66 % of the anabolic effect of Testosterone with only 27 % of its androgenic activity. Human anecdotal reports describe a clean, energized feeling with steady recomp results.

Why It Stands Out

  • CNS Stimulation: Users cite mild nootropic effect and elevated mood, making dieting phases easier.
  • Joint Friendly: Lacks drying effect of DHT derivatives—comfortable for high-volume training.
  • Minimal Bloat: Non-aromatizing and does not significantly alter mineral balance.

Practical Use

Goal Dose Length Notes
Recomp 10 mg ED 8 wk Good first SARM cycle.
Bridge 5 mg ED 8-12 wk Maintains muscle between steroid blasts.

Safety & Side-Effects

  • Suppression: Mild–moderate; mini-PCT often sufficient.
  • Liver: No significant hepatotoxic signal; monitor ALT/AST as precaution.
  • Lipids: Slight HDL reduction; fish oil recommended.

Bottom Line: ACP-105 offers a gentle introduction to SARMs with a favourable safety-to-reward ratio, ideal for athletes prioritizing recovery, mood and gradual body composition improvements.

Oral Mild

Quick Stats

Typical Dosage 10.0mg/week
Dosage Range 5.0-20.0mg
Load Multiplier 0.1x

Important ACP-105 Warnings

Early research – human data scarce

Long-term effects unknown

Properties

Aromatizes No
Hepatotoxic No
Injectable No
Oral Yes

Ratings

Anabolic Androgenic
80
93.0%
Ratio: 13.3:1
6
7.0%
vs Testosterone (100:100)
0.8x anabolic 0.1x androgenic